Canada on Wednesday approved the use of the Pfizer-BioNTech vaccine in children aged 12 years and up, becoming the first nation to do so. "This is the first vaccine authorized in Canada for the prevention of Covid-19 in children and marks a significant milestone in Canada's fight against the pandemic," Health Canada chief medical advisor Supriya Sharma told a news conference.

Canada becomes first country to authorise Pfizer Covid vaccine for kids age 12 and up

In a bid to make the country completely covid-free, the UK government will be offering a third shot of the coronavirus vaccines to everyone aged above 50 in the autumn.

UK: Locals above 50 to be given third dose against coronavirus in autumn: Reports

According to reports, the US Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week. The announcement is set to come a month after the company founded the vaccine is already authorized for those age 16 and older, also provided protection for the younger group.

US: FDA to approve Pfizer COVID-19 vaccine for teens by next week

Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19 vaccine, the company’s Chief Executive Officer (CEO) Albert Bourla said on Monday.

Pfizer in talks with Indian govt over expedited approval of COVID-19 vaccine

Pfizer said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as India insists on small local trials for foreign shots despite a record surge in infections and shortage of doses.

Told India no safety concerns with Covid vaccine, says Pfizer

The United States is expected to authorise the Pfizer-BioNTech Covid vaccine for children age 12 and up by early next week, US media reported on Monday. Pfizer has applied for emergency use authorisation for its Covid vaccine for children and teenagers between ages 12 and 15, according to CNN, citing a government official.

US to authorise Pfizer vaccine for age 12 and up: Report

Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

Pfizer donates 'largest humanitarian relief' worth $70 million to India

Pfizer Inc's shipment of COVID-19 vaccine to Mexico this week includes doses made in its US plant, the first of what are expected to be ongoing exports of its shots from the United States, a source familiar with the matter told Reuters on Thursday.

Pfizer begins to export US-made COVID-19 shots, first doses sent to Mexico

BioNTech said that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm's CEO Ugur Sahin asserted that it was 'in the final stretches' of preparing its submission for European regulatory approval.

BioNTech eyes COVID-19 vaccine for 12-15-year-olds from June in Europe

Pfizer/BioNTech said on Friday they have asked European regulators to authorise their Covid-19 vaccine for 12- to 15-year-olds, a move seen as a crucial step towards achieving herd immunity.

Pfizer/BioNTech seek Covid jab approval for 12-15-year-olds in EU

Pfizer Inc's shipment of COVID-19 vaccine to Mexico this week includes doses made in its US plant, the first of what are expected to be ongoing exports of its shots from the United States.

Pfizer to export COVID-19 shots from its US plant, first doses sent to Mexico

BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm's CEO Ugur Sahin told Der Spiegel weekly that it was "in the final stretches" of preparing its submission for European regulatory approval.

BioNTech eyes Covid vaccine for 12-15 year olds from June in Europe

Britain will buy 60 million more doses of Pfizer/BioNTech's COVID-19 vaccine, health minister Matt Hancock said, in a deal that more than doubles the country's supply of the shot ahead of a booster programme later this year.

Britain orders 60,000,000 Pfizer COVID-19 shots for booster programme 

Pfizer CEO has said that an oral drug to treat novel coronavirus could be ready by the end of the year. Pfizer-BioNTech's coronavirus vaccine has been used in various European countries and the United States and has a very high efficacy as compared to its competitors.

Pfizer CEO says oral drug to treat coronavirus could be ready by end of 2021

The co-founder of BionNTech on Wednesday said that testing of the coronavirus variant first found in India is underway and expressed confidence its vaccine will work against the strain.

BioNTech founder 'confident' its Covid vaccine willl work against strain first found in India

British lawmakers called on the government to publish all communications with pharmaceutical companies to understand if private lobbying influenced its opposition to a waiver of intellectual property rules for COVID-19 vaccines.

British lawmakers ask government to publish big pharma lobbying messages

Israel's Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people, who had received Pfizer's COVID-19 vaccine, though it has not yet drawn any conclusions.

Israel examining heart inflammation cases in people, who received Pfizer COVID-19 shot 

Pfizer, the US pharma giant, is planning to make a new version of its Covid vaccine that can be stored in standard freezer and comes ready for use. Currently, the Pfizer vaccine needs to be stored at minus 70 degrees Celsius.

New version of Pfizer Covid vaccine won't need ultra-low temperature for storage

One shot of the Oxford/AstraZeneca or Pfizer/BioNTech vaccine reduces coronavirus infections by nearly two-thirds and protects older and more vulnerable people as much as younger, healthy individuals, a study has found.

One dose of Pfizer or Oxford jab reduces coronavirus infection rate by 65%, says study

Australia will reduce the number of its citizens able to return from India and other red-zone countries to contain the risk of more virulent strains of COVID-19 spreading, the government said on Thursday as it announced changes in its vaccination programme.

Australia to cut flights from India to contain virus risk

The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found.

South African variant may 'break through' Pfizer vaccine protection, says study

Have you received both your doses of the Wuhan Virus vaccine? The CEO of Pfizer says you'll likely need a 3rd dose. Will other vaccine-makers follow suit? Watch this report by WION's Palki Sharma to find out.

Gravitas: Why do we need a third vaccine dose?

If you have been administered the Pfizer coronavirus vaccine, you might need a third dose, as per the company’s CEO Albert Bourla. The CEO has claimed that people may need a booster shot within 12 months of fully getting vaccinated.

Two's not the end: Pfizer CEO hints at need for third dose of coronavirus vaccine

Top U.N., financial and vaccine officials on Thursday urged rich countries to donate excess COVID-19 vaccine doses to a program supplying lower-income countries in a bid to end the pandemic and get the global economy back on track.

Global officials urge rich countries to donate excess COVID-19 vaccines, money to help end the pandemic

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news